Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05856669 · ClinicalTrials.gov registry record · NA

The Effects of Mirror-Based Virtual Reality Systems and Recalibration Software on Upper Extremity Function in Individuals Experiencing Hemiparesis Post-Stroke

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
1
Enrollment target

NCT05856669: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT05856669 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05856669, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

The goal of this study is to learn about the benefits of using a virtual reality gaming system that can be adjusted for a person who has upper arm weakness from stroke. The main question it aims to answer is whether strength and movement in the upper arm be improved by use of the gaming system. Participants will be asked to complete initial measurements of upper arm function, play a video game for one hour, four times a week for five weeks, and repeat the measurements of upper arm function at the end.

Primary Outcome

Measured via goniometer

Interventions

  • DEVICE Virtual reality gaming

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2023-09-01
Est. Completion 2023-10-16
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT05856669 record still lists

NCT05856669 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Virtual reality gaming is the first listed.

NCT05856669 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05856669 about?

NCT05856669 is a clinical study titled "The Effects of Mirror-Based Virtual Reality Systems and Recalibration Software on Upper Extremity Function in Individuals Experiencing Hemiparesis Post-Stroke". The goal of this study is to learn about the benefits of using a virtual reality gaming system that can be adjusted for a person who has upper arm weakness from stroke. The main question it aims to answer is whether strength and movement in the upper arm be improved by use of the gaming system. Par...

What is the current status of trial NCT05856669?

This trial is currently completed. It is a NA study. The enrollment target is 1 participants. The study started on 2023-09-01. Estimated completion is 2023-10-16.

What interventions are being tested in trial NCT05856669?

The interventions under investigation include: Virtual reality gaming (DEVICE).

Who is sponsoring clinical trial NCT05856669?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05856669's enrollment target sits among peer trials

1 2001st of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05856669, the US trial registry maintained by the National Library of Medicine. NCT05856669 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.